CLL/SLL
Clinical trials for CLL/SLL explained in plain language.
Never miss a new study
Get alerted when new CLL/SLL trials appear
Sign up with your email to follow new studies for CLL/SLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called LP-168 in adults whose B-cell blood cancers have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the drug behaves in the body. Researchers will also look for e…
Matched conditions: CLL/SLL
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
New drug combo aims to keep blood cancer at bay longer
Disease control Recruiting nowThis global study is testing whether adding a new drug called lisaftoclax to a standard cancer therapy (BTK inhibitor) works better for controlling chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in patients who have already been on that standard therapy. About …
Matched conditions: CLL/SLL
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to help leukemia patients stop treatment
Disease control Recruiting nowThis study is testing whether adding a drug called epcoritamab to standard treatment can help patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. The goal is to see if this combination can eliminate nearly all cancer ce…
Matched conditions: CLL/SLL
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough blood cancers: first patients test experimental drug
Disease control Recruiting nowThis is the first study in people testing a new drug called ZE50-0134 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The main goals are to find a safe dose and see how the body h…
Matched conditions: CLL/SLL
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for leukemia patients when first treatment fails
Disease control Recruiting nowThis study is testing whether a combination of two targeted drugs, venetoclax and acalabrutinib, can help control chronic lymphocytic leukemia (CLL) in patients whose cancer has returned after their first round of treatment. The trial will enroll 60 adults who previously received…
Matched conditions: CLL/SLL
Phase: PHASE2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC